Held on 24 May 2016
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 24 May 2016 at 3.30 p.m. inter alia, has considered and approved the following:1. Declared Final dividend at the rate of 50% i.e. Re. 0.50 per share.
2. Pursuant to section 188 of the Companies Act, 2013 approved the appointment of Vishal Rao and the reappointment of Gagan Sharma and Arjun Ashra in the managerial capacity.
3. Reappointment of Statutory Auditor of the Company.
4. Reappointment of Internal Auditor of the Company for the F.Y. 2016-17.
5. Reappointment of Secretarial Auditor for the F.Y. 2016-17.
6. Accepted the resignation of Hira Sadhak an Independent Director with effect from 17 May 2016.
7. Appointed of Santosh Parab as an Independent Director with effect from 24 May 2016.
Powered by Capital Market - Live News
